🇺🇸 BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit

🇺🇸 NEW YORK, Sept. 13, 2026 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the “Class Period”)…. Source: prnewswire Country: United States

🇺🇸 REGN INVESTOR DEADLINE TOMORROW: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

🇺🇸 SAN DIEGO, Sept. 13, 2026 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) common stock between August 1, 2025 and May 15, 2026, inclusive (the “Class Period”), have until tomorrow, Monday, September… Source: prnewswire Country: United States

🇺🇸 Quantinuum participará en la 5ª Conferencia anual Growth Frontiers de Piper Sandler

🇺🇸 BROOMFIELD, Colo., 13 de septiembre de 2026 /PRNewswire/ — Quantinuum Inc. (Nasdaq: QNT) (la “Compañía”), un líder en computación cuántica, anunció hoy que miembros de su equipo directivo participarán en la 5ª Conferencia Anual Growth Frontiers de Piper Sandler, que tendrá lugar del 14… Source: prnewswire Country: United States